Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TICAM1 Protein (AA 29-204) (His tag)

TICAM1 Spezies: Human Wirt: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses WB, ELISA
Produktnummer ABIN7125415
  • Target Alle TICAM1 Proteine anzeigen
    TICAM1 (Toll-Like Receptor Adaptor Molecule 1 (TICAM1))
    Protein-Typ
    Recombinant
    Proteineigenschaft
    AA 29-204
    Spezies
    • 3
    • 2
    Human
    Quelle
    • 2
    • 2
    • 1
    Escherichia coli (E. coli)
    Aufreinigungstag / Konjugat
    Dieses TICAM1 Protein ist gelabelt mit His tag.
    Applikation
    Western Blotting (WB), ELISA
    Reinheit
    Greater than 95 % by SDS-PAGE gel analyses
    Sterilität
    0.2 μm filtered
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
    Buffer
    Lyophilized from a 0.2 μm filtered solution in PBS with 5 % trehalose, pH 7.4
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
    Haltbarkeit
    12 months
  • Target
    TICAM1 (Toll-Like Receptor Adaptor Molecule 1 (TICAM1))
    Andere Bezeichnung
    TRIF (TICAM1 Produkte)
    Synonyme
    IIAE6 Protein, MyD88-3 Protein, PRVTIRB Protein, TICAM-1 Protein, TRIF Protein, AW046014 Protein, AW547018 Protein, trif Protein, toll like receptor adaptor molecule 1 Protein, toll-like receptor adaptor molecule 1 Protein, TICAM1 Protein, Ticam1 Protein, ticam1 Protein
    Hintergrund
    PRVTIRB, TICAM 1, TICAM1, TRIF
    Molekulargewicht
    20.8 kDa
    UniProt
    Q8IUC6
    Pathways
    TLR Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades
Sie sind hier: